Determinants of the severity and extent of coronary artery disease in patients with type-2 diabetes and in nondiabetic subjects.
BACKGROUND
Factors predicting the anatomic distribution and the severity and extent of coronary atherosclerosis in patients with clinically manifest coronary artery disease (CAD) for type-2 diabetic patients could be different than those for nondiabetic patients.


OBJECTIVE
To study the determinants of severity and extent of CAD in consecutive patients with type 2 diabetes mellitus, compared with those for matched nondiabetic patients, undergoing clinically indicated coronary angiography.


METHODS
Coronary angiograms of 48 men and seven women with type-2 diabetes and an equal number of nondiabetic subjects were analyzed quantitatively. Scores reflecting severity and extent of CAD were compared with potential risk factors using univariate correlation analyses and multivariate regression models.


RESULTS
For the diabetics, a global coronary atheroma burden index was independently and directly related to age (P = 0.022) and to level of intermediate-density lipoprotein cholesterol (P = 0.055), and inversely to level of particles of a subtype of high-density lipoprotein (P = 0.022). Several angiographic indexes were related to the duration of diabetes and control of glycemia. For the nondiabetic group, global atheroma burden was independently related to age (P = 0.028), a history of hypertension (P = 0.028), and concentration of low-density lipoprotein (P = 0.013), and inversely to level of apolipoprotein A-I (P = 0.008). The duration of coronary disease and a history of smoking were also predictive of severe coronary atherosclerosis among nondiabetic patients.


CONCLUSIONS
Classical risk factors are strong predictors of the severity and extent of coronary atherosclerosis in nondiabetic patients, but the most important determinants for type-2 diabetic patients are levels of triglyceride-rich lipoproteins and apolipoprotein A-I-containing particles of high-density lipoprotein, and factors directly related to diabetes.
Syvänne
M
M
Department of Medicine, Helsinki University Central Hospital, Finland. mikko.syvanne@hus.fi
Pajunen
P
P
Kahri
J
J
Lahdenperä
S
S
Ehnholm
C
C
Nieminen
M S
MS
Taskinen
M R
MR
D000368:Aged; D016632:Apolipoprotein A-I / Q000097:blood; D016022:Case-Control Studies; D002784:Cholesterol / Q000097:blood; D017023:Coronary Angiography; D003324:Coronary Artery Disease / Q000000981:diagnostic imaging / Q000453:epidemiology; D003327:Coronary Disease / Q000000981:diagnostic imaging / Q000453:epidemiology*; D003924:Diabetes Mellitus, Type 2 / Q000150:complications*; D005260:Female; D006801:Humans; D016014:Linear Models; D008074:Lipoproteins / Q000097:blood; D008297:Male; D012307:Risk Factors; D012720:Severity of Illness Index
D016632:Apolipoprotein A-I; D008074:Lipoproteins; D002784:Cholesterol